KR890015995A - 프로판아민 유도체 - Google Patents

프로판아민 유도체

Info

Publication number
KR890015995A
KR890015995A KR1019890004579A KR890004579A KR890015995A KR 890015995 A KR890015995 A KR 890015995A KR 1019890004579 A KR1019890004579 A KR 1019890004579A KR 890004579 A KR890004579 A KR 890004579A KR 890015995 A KR890015995 A KR 890015995A
Authority
KR
South Korea
Prior art keywords
compound
formula
pharmaceutically acceptable
methyl
hydrogen
Prior art date
Application number
KR1019890004579A
Other languages
English (en)
Inventor
웨인 로버트슨 데이비드
타이와이 왕 데이비드
Original Assignee
메리 앤 터커
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메리 앤 터커, 일라이 릴리 앤드 캄파니 filed Critical 메리 앤 터커
Publication of KR890015995A publication Critical patent/KR890015995A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/24—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Abstract

내용 없음

Description

프로판아민 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 일반식(Ⅰ)의 화합물 또는 이의 약제학적으로 허용되는 산부가염.
    상기식에서, R1은(C1-C2알킬) -S(O)p-, CF3S-, CF3O-, H2NOC-, H2NSO2-, 또는 CH3SO2NH-이고, R2는 수소 또는 메틸이며, p는 0,1 또는 2이다.
  2. 제 1 항에 있어서, R2가 수소인 화합물.
  3. 제 1 항에 있어서, R2가 메틸인 화합물.
  4. Ｎ-메틸-γ-[4-(메틸티오)페녹시]벤젠프로판아민 또는 이의 약제학적으로 허용되는 산부가염.
  5. Ｎ,Ｎ-디메틸-γ-[4-(메틸티오)페녹시]-벤젠프로판아민 또는 이의 약제학적으로 허용되는 산부가염.
  6. 제 1 항 내지 5항중 어느 한항에서 청구된 일반식(Ⅰ)의 화합물 또는 이의 약제학적으로 허용되는 염을 하나 이상의 약제학적으로 허용되는 담체. 희석제 또는 부형제와 함께 함유함을 특징으로 하는 약제학적 제제.
  7. (ａ) 일반식(Ⅱ)의 페닐프로필아민을 일반식(Ⅲ)의 벤젠 유도체와 반응시키거나 ; (ｂ) R2가 메틸인 일반식(Ⅰ)의 화합물을 탈메틸화시켜 R2가 수소인 일반식(Ⅰ)의 화합물을 수득하거나 ; (ｃ) R1이 H2N-인 일반식(Ⅰ)의 아미노 화합물을 메탄설포닐 클로라이드로 처리하여, R1이 CH3SO2NH-인 일반식(Ⅰ)의 화합물을 수득하거나 ; (ｄ) R2가 (C1-C2알킬)-S(O)p-이고, ｐ가 0 또는 1인 일반식(Ⅰ)의 화합물을 산화시켜 ｐ가 1 또는 2인 화합물을 수득하고 ; (ｅ)임의로 수득된 생성물을 약제학적으로 허용되는 염으로 전환시킴을 특징으로 하여 제 1 항 내지 5항중 어느 한항에서 청구된 일반식(Ⅰ)의 화합물 또는 이의 약제학적으로 허용되는 염을 제조하는 방법.
    상기식에서 R1및 R2는 제 1 항에서 정의한 바와 같고, Ｘ 및 Ｙ중 하나는 하이드록시이며 다른 하나는 우수이탈 그룹이다.
  8. 제 7 항에 따른 방법으로 제조된 제 1 항 내지 5항중 어느 한 항에서 정의된 일반식(Ⅰ)의 화합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890004579A 1988-04-08 1989-04-07 프로판아민 유도체 KR890015995A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17936888A 1988-04-08 1988-04-08
US07/179368 1988-04-08

Publications (1)

Publication Number Publication Date
KR890015995A true KR890015995A (ko) 1989-11-27

Family

ID=22656301

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890004579A KR890015995A (ko) 1988-04-08 1989-04-07 프로판아민 유도체

Country Status (19)

Country Link
EP (1) EP0336753B1 (ko)
JP (1) JPH0285236A (ko)
KR (1) KR890015995A (ko)
CN (1) CN1036562A (ko)
AT (1) ATE78029T1 (ko)
AU (1) AU611794B2 (ko)
CA (1) CA1337128C (ko)
DE (1) DE68901994T2 (ko)
DK (1) DK165489A (ko)
ES (1) ES2033525T3 (ko)
GR (1) GR3005662T3 (ko)
HU (1) HU205344B (ko)
IE (1) IE891122L (ko)
IL (1) IL89854A (ko)
NZ (1) NZ228636A (ko)
PH (1) PH27144A (ko)
PT (1) PT90212B (ko)
SU (1) SU1750421A3 (ko)
ZA (1) ZA892517B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK630987D0 (da) * 1987-12-01 1987-12-01 Ferrosan As Aryloxyphenylpropylaminer, deres fremstilling og anvendelse
FI912280A (fi) * 1990-05-17 1991-11-18 Lilly Co Eli Kiral syntes av 1-aryl-3-aminopropan-1 -oler.
EP0537915B1 (en) * 1991-09-27 1995-07-12 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines as norepinephrine inhibitors
US5281624A (en) * 1991-09-27 1994-01-25 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
EP0576766A1 (en) * 1992-06-29 1994-01-05 Novo Nordisk A/S Propanolamine derivatives, their preparation and use
IL110857A0 (en) * 1993-09-09 1994-11-28 Lilly Co Eli Cessation of tobacco use
US5936124A (en) * 1998-06-22 1999-08-10 Sepacor Inc. Fluoxetine process from benzoylpropionic acid
US6025517A (en) * 1998-08-03 2000-02-15 Sepracor Inc. Fluoxetine process from benzoylacetonitrile
ITMI20061987A1 (it) * 2006-10-16 2008-04-17 Archimica Srl Processo per la sintesi di arilossipropilammine ed eteroarilossipropilammine.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
DE2732750A1 (de) * 1977-07-20 1979-02-08 Merck Patent Gmbh Basische thioaether und verfahren zu ihrer herstellung
US4243681A (en) * 1977-10-11 1981-01-06 Mead Johnson & Company Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof
US4147805A (en) * 1978-07-28 1979-04-03 Mead Johnson & Company Alkylthiophenoxyalkylamines and the pharmaceutical use thereof
GB2060622B (en) * 1979-09-14 1983-05-25 Wyeth John & Brother Ltd 3-aryl-3-aryloxyalkylamines
US4569801A (en) * 1984-10-15 1986-02-11 Eli Lilly And Company Alkylsulfonamidophenylalkylamines

Also Published As

Publication number Publication date
NZ228636A (en) 1990-12-21
HUT54976A (en) 1991-04-29
GR3005662T3 (ko) 1993-06-07
HU205344B (en) 1992-04-28
ATE78029T1 (de) 1992-07-15
DE68901994D1 (de) 1992-08-13
DK165489A (da) 1989-10-09
ES2033525T3 (es) 1993-03-16
CN1036562A (zh) 1989-10-25
EP0336753B1 (en) 1992-07-08
DK165489D0 (da) 1989-04-06
PT90212B (pt) 1994-06-30
CA1337128C (en) 1995-09-26
JPH0285236A (ja) 1990-03-26
SU1750421A3 (ru) 1992-07-23
PH27144A (en) 1993-04-02
EP0336753A1 (en) 1989-10-11
ZA892517B (en) 1990-12-28
PT90212A (pt) 1989-11-10
IE891122L (en) 1989-10-08
AU3252889A (en) 1989-10-12
AU611794B2 (en) 1991-06-20
IL89854A (en) 1994-02-27
DE68901994T2 (de) 1993-02-25

Similar Documents

Publication Publication Date Title
KR880007433A (ko) 3-아릴옥시-3-치환된 프로판아민
KR880012526A (ko) l-페닐-3-나프탈레닐옥시프로판아민
ES2064461T3 (es) Derivados de xantina, procedimiento para su preparacion y composicion farmaceutica.
KR890015995A (ko) 프로판아민 유도체
KR860008111A (ko) 인딘과 나프탈렌 유도체의 제조방법
KR910014380A (ko) 이미자조피리다진 화합물, 그의 제법 및 용도
DE69013528D1 (de) Eine Perfluoralkylgruppe enthaltende Verbindung.
AU583311B2 (en) N-(6-Methoxy-5-(perfluoroalkyl)-1-naptholyl)-N- methylglycines and their thionaphthoyl analogs
KR950032183A (ko) 글루코피라노사이드 벤조티오펜
KR830010106A (ko) 피페라진 유도체의 제조방법
KR840007228A (ko) 트리아졸 유도체의 제조방법
KR840005717A (ko) 벤즈아미드 유도체의 제조방법
AU563426B2 (en) 3-alkoxy-2(n-pyrrolidino)-n-pyridyl-n-furyl (or thienyl) methyl propylamines
KR850005435A (ko) 3-알콕시-2-(n-피롤리디노)-n-피리미디닐-또는 n-피라지닐 프로필아민의 제조방법
KR890009896A (ko) 디옥사조신 유도체, 그의 제법 및 그를 함유하는 조성물
NO178137C (no) Fremgangsmåte for fremstilling av et polyprenylholdig farmasöytisk preparat i form av harde kapsler
KR920009830A (ko) 신규 퓨린 유도체
ES8707505A2 (es) Mejoras en el objeto de la patente de invencion n.541.911 por procedimiento de obtencion de nuevos derivados de alfa-(alquilaminopropionil)-tiofeno sustituidos en el anillo tiofenico
KR910000786A (ko) 콜레스타디엔 유도체, 이의 제조방법 및 HMG-CoA 환원제를 저해하는 작용을 하는 약제로서의 이의 용도
PT91427A (pt) Processo para a preparacao de composicoes farmaceuticas contendo carbinoloimidazois anti-inflamatorios
PT89356A (pt) Processo para a preparacao de derivados da 2-amino-tetra-hidro-isoquinolina e de composicoes farmaceuticas contendo os mesmos
SE8303410D0 (sv) Benzene derivatives, processes for their preparation and pharmaceutical compositions comprising them
KR830005157A (ko) 페녹시-아미노프로판올 유도체의 제조방법
KR860007215A (ko) 벤조아미드 유도체의 제조방법
KR880006185A (ko) 신규 α-클로로케톤 유도체 및 그 제조법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid